Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing—A Prospective Feasibility Study

SIMPLE SUMMARY: Despite the improvement of the prognosis of metastatic melanoma patients through the implementation of targeted and immunotherapies, there is a need to identify biomarkers to predict and monitor treatment response. Therefore, we performed sequencing of paired melanoma tissue biopsies...

Descripción completa

Detalles Bibliográficos
Autores principales: Berger, Marina, Thueringer, Andrea, Franz, Doritt, Dandachi, Nadia, Talakić, Emina, Richtig, Georg, Richtig, Erika, Rohrer, Peter Michael, Koch, Lukas, Wolf, Ingrid Hildegard, Koch, Catharina, Rainer, Barbara Margaretha, Koeller, Maximilian, Pichler, Martin, Gerritsmann, Hanno, Kashofer, Karl, Aigelsreiter, Ariane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233754/
https://www.ncbi.nlm.nih.gov/pubmed/34205831
http://dx.doi.org/10.3390/cancers13123101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233754/
https://www.ncbi.nlm.nih.gov/pubmed/34205831
http://dx.doi.org/10.3390/cancers13123101

Ejemplares similares